✦ LIBER ✦

Single-dose pharmacokinetics of aerosol MP-376 (levofloxacin solution for inhalation) in cystic fibrosis patients: PK-PD implications

✍ Scribed by P.C. Griffith; C. Hansen; T. Pressler; T. Baichen; T.J. Jensen; D.E. Geller; K. Kesser; J. Rock; M. Surber; K. Bostian; M.N. Dudley

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics (PK) of aerosol MP-376

✍ D.E. Geller; P.A. Flume; D.C. Griffith; E. Morgan; D. White; J. Loutit; M.N. Dud 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 54 KB

88 Levofloxacin pharmacokinetics (PK) af

✍ G.L. Kearns; C.M. Rubino; D.C. Griffith; D.E. Geller; A. Forrest; S.M. Bhavnani; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Levofloxacin reduces inflammatory cytoki

✍ Ruslan Tsivkovskii; Mojgan Sabet; Ziad Tarazi; David C. Griffith; Olga Lomovskay 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB

Effects of inhaled MP-376 (aeroquin, lev

✍ P. Flume; D.E. Geller; L. Sindel; D. Staab; R. Fischer; J. Riethmüller; J. Louti 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 54 KB